BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 33539891)

  • 1. Molecular Strategies Underlying Porphyromonas gingivalis Virulence.
    Lunar Silva I; Cascales E
    J Mol Biol; 2021 Apr; 433(7):166836. PubMed ID: 33539891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type IX secretion system is pivotal for expression of gingipain-associated virulence of Porphyromonas gingivalis.
    Benedyk M; Marczyk A; Chruścicka B
    Mol Oral Microbiol; 2019 Dec; 34(6):237-244. PubMed ID: 31432617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PorZ, an Essential Component of the Type IX Secretion System of
    Madej M; Nowakowska Z; Ksiazek M; Lasica AM; Mizgalska D; Nowak M; Jacula A; Bzowska M; Scavenius C; Enghild JJ; Aduse-Opoku J; Curtis MA; Gomis-Rüth FX; Potempa J
    mBio; 2021 Feb; 12(1):. PubMed ID: 33622730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PGN_0297 is an essential component of the type IX secretion system (T9SS) in Porphyromonas gingivalis: Tn-seq analysis for exhaustive identification of T9SS-related genes.
    Naito M; Tominaga T; Shoji M; Nakayama K
    Microbiol Immunol; 2019 Jan; 63(1):11-20. PubMed ID: 30599082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of an Skp-Like Protein, PGN_0300, in the Type IX Secretion System of Porphyromonas gingivalis.
    Taguchi Y; Sato K; Yukitake H; Inoue T; Nakayama M; Naito M; Kondo Y; Kano K; Hoshino T; Nakayama K; Takashiba S; Ohara N
    Infect Immun; 2016 Jan; 84(1):230-40. PubMed ID: 26502912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of inactivation of the Arg- and/or Lys-gingipain gene on selected virulence and physiological properties of Porphyromonas gingivalis.
    Grenier D; Roy S; Chandad F; Plamondon P; Yoshioka M; Nakayama K; Mayrand D
    Infect Immun; 2003 Aug; 71(8):4742-8. PubMed ID: 12874356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementation in
    Glew MD; Gorasia DG; McMillan PJ; Butler CA; Veith PD; Reynolds EC
    J Bacteriol; 2021 Apr; 203(10):. PubMed ID: 33685973
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathogenesis of Important Virulence Factors of
    Jia L; Han N; Du J; Guo L; Luo Z; Liu Y
    Front Cell Infect Microbiol; 2019; 9():262. PubMed ID: 31380305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of the phosphatidylinositol 3-kinase/Akt signaling pathway by Porphyromonas gingivalis gingipains RgpA, RgpB, and Kgp.
    Nakayama M; Inoue T; Naito M; Nakayama K; Ohara N
    J Biol Chem; 2015 Feb; 290(8):5190-5202. PubMed ID: 25564612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods for Functional Characterization of the Type IX Secretion System of Porphyromonas gingivalis.
    Sato K
    Methods Mol Biol; 2021; 2210():123-133. PubMed ID: 32815133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetics of Porphyromonas gingivalis: gingipains and other virulence factors.
    Nakayama K
    Curr Protein Pept Sci; 2003 Dec; 4(6):389-95. PubMed ID: 14683425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolytic Activity-Independent Activation of the Immune Response by Gingipains from Porphyromonas gingivalis.
    Ciaston I; Budziaszek J; Satala D; Potempa B; Fuchs A; Rapala-Kozik M; Mizgalska D; Dobosz E; Lamont RJ; Potempa J; Koziel J
    mBio; 2022 Jun; 13(3):e0378721. PubMed ID: 35491845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spheres of influence: Porphyromonas gingivalis outer membrane vesicles.
    Gui MJ; Dashper SG; Slakeski N; Chen YY; Reynolds EC
    Mol Oral Microbiol; 2016 Oct; 31(5):365-78. PubMed ID: 26466922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative proteomic analysis of the type IX secretion system mutants in Porphyromonas gingivalis.
    Gorasia DG; Glew MD; Veith PD; Reynolds EC
    Mol Oral Microbiol; 2020 Apr; 35(2):78-84. PubMed ID: 32040252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of lipopolysaccharide receptor CD14 from the surface of human macrophage-like cells mediated by Porphyromonas gingivalis outer membrane vesicles.
    Duncan L; Yoshioka M; Chandad F; Grenier D
    Microb Pathog; 2004 Jun; 36(6):319-25. PubMed ID: 15120158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemin binding by Porphyromonas gingivalis strains is dependent on the presence of A-LPS.
    Rangarajan M; Aduse-Opoku J; Paramonov NA; Hashim A; Curtis MA
    Mol Oral Microbiol; 2017 Oct; 32(5):365-374. PubMed ID: 28107612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of gingipains R in the pathogenesis of Porphyromonas gingivalis-mediated periodontal disease.
    Genco CA; Potempa J; Mikolajczyk-Pawlinska J; Travis J
    Clin Infect Dis; 1999 Mar; 28(3):456-65. PubMed ID: 10194062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro models of tissue penetration and destruction by Porphyromonas gingivalis.
    Andrian E; Grenier D; Rouabhia M
    Infect Immun; 2004 Aug; 72(8):4689-98. PubMed ID: 15271930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A conditional gene expression system in Porphyromonas gingivalis for study of the secretion mechanisms of lipoproteins and T9SS cargo proteins.
    Sasaki Y; Shoji M; Sueyoshi T; Shibata S; Matsuo T; Yukitake H; Wolf M; Naito M
    Mol Oral Microbiol; 2023 Aug; 38(4):321-333. PubMed ID: 37339018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gingipains as candidate antigens for Porphyromonas gingivalis vaccine.
    Nakagawa T; Saito A; Hosaka Y; Ishihara K
    Keio J Med; 2003 Sep; 52(3):158-62. PubMed ID: 14529148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.